Clinical and Translational Research
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2541-2554
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2541
Figure 2
Figure 2 Online web nomograms for predicting 1-, 3-, and 5-year. A: Overall survival for Siewert type II adenocarcinoma of the esophagogastric junction (AEG) underwent radical gastrectomy with neoadjuvant chemotherapy; B: Disease-specific survival for Siewert type II AEG underwent radical gastrectomy with neoadjuvant chemotherapy. OS: Overall survival; DSS: Disease-specific survival; ACT: Adjuvant chemotherapy.